We are live on
!
Find out more
NewAmsterdam Pharma Warrant
NAMSW
NAMSW
USD
At close
Updated
Pre-market
After hours
1 day
5 days
1 month
3 months
6 months
Year to date
1 year
5 years
10 years
New
Increased
Maintained
Reduced
Closed
Mega AUM
Over $200B
Large AUM
$10B to $200B
Mid AUM
$2B to $10B
Small AUM
$250M to $2B
Micro AUM
Under $250M
Less than 10%
Less than 20%
Less than 40%
Less than 60%
Less than 80%
| # | Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|---|
| 1 |
FLSM
1
Frazier Life Sciences Management
Palo Alto,
California
| $10.7M | – | – | – |
|
| 2 |
RCM
2
RA Capital Management
Boston,
Massachusetts
| $7.12M | – | – | – |
|
| 3 |
AAA
3
Affinity Asset Advisors
New York
| $5.34M | – | – | – |
|
| 4 |
BCLSI
4
Bain Capital Life Sciences Investors
Boston,
Massachusetts
| $2.14M | – | – | – |
|
| 5 |
DM
5
Deerfield Management
New York
| $1.98M | – | – | – |
|
| 6 |
AC
6
Aristeia Capital
Greenwich,
Connecticut
| $343K | – | – | – |
|
| 7 |
WAM
7
Wolverine Asset Management
Chicago,
Illinois
| $319K | +$280K | +12,798 | +602% |
|
| 8 |
VI
8
Vestcor Inc
Fredericton,
New Brunswick, Canada
| $143K | – | – | – |
|
| 9 |
9
UBS Group
Zurich,
Switzerland
| $8.52K | +$1.03K | +47 | +12% |
|